Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Tobacco Use Disorder 2Rectal Neoplasms 2Precancerous Conditions 2Colorectal Neoplasms 2Colonic Neoplasms 2Barrett Esophagus 2Thromboembolism 1Squamous Cell Carcinoma of Head and Neck 1Smoking Cessation 1Salivary Gland Neoplasms 1Prostatic Neoplasms 1Multiple Pulmonary Nodules 1Lung Neoplasms 1Leukoplakia, Oral 1Leukemia, Hairy Cell 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Adenomatous Polyps 1Adenocarcinoma Of Esophagus 1

Interventions

Dalteparin 2alvocidib 1Warfarin 1Immunoenzyme Techniques 1Gemcitabine 1Clopidogrel 1Bleeding Time 1Aspirin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Thromboembolism × Aspirin × Clear all
NCT00020189 2013-06-19

Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer

National Cancer Institute (NCI)

Phase 2 Completed
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Salivary Gland Neoplasms, Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡